Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Mindong Lijiexun Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, production, and sale of chemical drug preparations. The company's product portfolio primarily includes freeze-dried powder injections, small-volume injections, and solid oral dosage forms across therapeutic areas such as the digestive system, nervous system, and anti-infectives. Key products include Citicoline Sodium for injection and Omeprazole Sodium for injection. Headquartered in Fuding, Fujian Province, the company operates modern manufacturing facilities compliant with GMP standards and maintains a significant presence in the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fujian Mindong Lijiexun Pharmaceutical.